Apolipoprotein C-I reduces cholesteryl esters selective uptake from LDL and HDL by binding to HepG2 cells and lipoproteins.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Biochimica et Biophysica Acta

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.bbalip.2009.09.001PMID 19761869
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The ApoC-I Content of VLDL Particles is Associated with Plaque Size in Persons with Carotid Atherosclerosis

  2008cited by this paper
• Apolipoprotein CI inhibits scavenger receptor BI and increases plasma HDL levels in vivo.

  2008cited by this paper
• Mouse CD36 Has Opposite Effects on LDL and Oxidized LDL Metabolism In Vivo

  2008cited by this paper
• Hepatic lipid accumulation in apolipoprotein C-I-deficient mice is potentiated by cholesteryl ester transfer proteins⃞ Published, JLR Papers in Press, October 19, 2006.

  2007cited by this paper
• Apolipoprotein CI aggravates atherosclerosis development in ApoE-knockout mice despite mediating cholesterol efflux from macrophages.

  2007cited by this paper
• The Role of Osteopontin in Recovery from Hind Limb Ischemia

  2007cited by this paper
• Endogenous apoC-I increases hyperlipidemia in apoE-knockout mice by stimulating VLDL production and inhibiting LPL Published, JLR Papers in Press, March 14, 2006.

  2006cited by this paper
• Opposite effect of caveolin-1 in the metabolism of high-density and low-density lipoproteins.

  2006cited by this paper
• A proteomic study of the apolipoproteins in LDL subclasses in patients with the metabolic syndrome and type 2 diabetes Published, JLR Papers in Press, July 1, 2005. DOI 10.1194/jlr.M500161-JLR200

  2005cited by this paper
• Apolipoproteins C-II and C-III inhibit selective uptake of low- and high-density lipoprotein cholesteryl esters in HepG2 cells.

  2005cited by this paper
• Physiological importance of SR-BI in the in vivo metabolism of human HDL and LDL in male and female mice Published, JLR Papers in Press, January 16, 2005. DOI 10.1194/jlr.M400165-JLR200

  2005cited by this paper
• Severe hypertriglyceridemia in human APOC1 transgenic mice is caused by apoC-I-induced inhibition of LPL Published, JLR Papers in Press, December 1, 2004. DOI 10.1194/jlr.M400301-JLR200

  2005cited by this paper
• Scavenger receptor class B type I is solely responsible for the selective uptake of cholesteryl esters from HDL by the liver and the adrenals in mice Published, JLR Papers in Press, August 16, 2004. DOI 10.1194/jlr.M400191-JLR200

  2004cited by this paper
• Localization and regulation of SR-BI in membrane rafts of HepG2 cells

  2004cited by this paper
• A quantitative analysis of apolipoprotein binding to SR-BI: multiple binding sites for lipid-free and lipid-associated apolipoproteins.

  2003cited by this paper
• The role of human and mouse hepatic scavenger receptor class B type I (SR-BI) in the selective uptake of low-density lipoprotein-cholesteryl esters.

  2003cited by this paper
• Lipid Free Apolipoprotein E Binds to the Class B Type I Scavenger Receptor I (SR-BI) and Enhances Cholesteryl Ester Uptake from Lipoproteins*

  2002cited by this paper
• Apolipoprotein AII enrichment of HDL enhances their affinity for class B type I scavenger receptor but inhibits specific cholesteryl ester uptake.

  2000cited by this paper
• Low- and high-density lipoprotein metabolism in HepG2 cells expressing various levels of apolipoprotein E.

  2000cited by this paper
• Dissociation of the High Density Lipoprotein and Low Density Lipoprotein Binding Activities of Murine Scavenger Receptor Class B Type I (mSR-BI) Using Retrovirus Library-based Activity Dissection*

  2000cited by this paper
• Apolipoprotein AII Enrichment of HDL Enhances Their Affinity for Class B Type I Scavenger Receptor but Inhibits Specific Cholesteryl Ester Uptake

  2000cited by this paper
• Human Apolipoprotein C-I Accounts for the Ability of Plasma High Density Lipoproteins to Inhibit the Cholesteryl Ester Transfer Protein Activity*

  2000cited by this paper
• Role of ApoCs in lipoprotein metabolism: functional differences between ApoC1, ApoC2, and ApoC3.

  1999cited by this paper
• Apolipoproteins of HDL can directly mediate binding to the scavenger receptor SR-BI, an HDL receptor that mediates selective lipid uptake.

  1997cited by this paper
• Plasma lipoprotein distribution of apoC-III in normolipidemic and hypertriglyceridemic subjects: comparison of the apoC-III to apoE ratio in different lipoprotein fractions.

  1997cited by this paper
• Identification of Scavenger Receptor SR-BI as a High Density Lipoprotein Receptor

  1996cited by this paper
• Regulation of scavenger receptor, class B, type I, a high density lipoprotein receptor, in liver and steroidogenic tissues of the rat.

  1996cited by this paper
• In the absence of the low density lipoprotein receptor, human apolipoprotein C1 overexpression in transgenic mice inhibits the hepatic uptake of very low density lipoproteins via a receptor-associated protein-sensitive pathway.

  1996cited by this paper
• Acceleration of uptake of LDL but not chylomicrons or chylomicron remnants by cells that secrete apoE and hepatic lipase.

  1994cited by this paper
• Expression cloning of SR-BI, a CD36-related class B scavenger receptor.

  1994cited by this paper
• Apolipoprotein C-I modulates the interaction of apolipoprotein E with beta-migrating very low density lipoproteins (beta-VLDL) and inhibits binding of beta-VLDL to low density lipoprotein receptor-related protein.

  1990cited by this paper
• Low binding capacity and altered O-linked glycosylation of low density lipoprotein receptor in a monensin-resistant mutant of Chinese hamster ovary cells.

  1987cited by this paper
• Metabolism of apolipoprotein C-I in normolipoproteinemic human subjects.

  1986cited by this paper
• Receptor-mediated endocytosis: concepts emerging from the LDL receptor system.

  1985cited by this paper
• Quantitative determination of apolipoproteins C-I and C-II in human plasma by separate electroimmunoassays.

  1981cited by this paper
• Effect of the human plasma apolipoproteins and phosphatidylcholine acyl donor on the activity of lecithin: cholesterol acyltransferase.

  1975cited by this paper
• The labelling of proteins to high specific radioactivities by conjugation to a 125I-containing acylating agent.

  1973cited by this paper
• Cofactor activity of protein components of human very low density lipoproteins in the hydrolysis of triglycerides by lipoproteins lipase from different sources.

  1973cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper
• THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS

  1949cited by this paper

• Apolipoprotein C1 stimulates the malignant process of renal cell carcinoma via the Wnt3a signaling

  2020cites this paper
• APOC1 is a Potential Prognostic Biomarker and Correlated With Immune Infiltration in ESCC

  2020cites this paper
• Apolipoprotein C1 promotes prostate cancer cell proliferation in vitro

  2018cites this paper
• Truncated apolipoprotein C-I induces apoptosis in neuroblastoma by activating caspases in the extrinsic and intrinsic pathways.

  2017cites this paper
• Lipoprotein Like Nanoparticles Used in Drug and Gene Delivery.

  2016cites this paper
• Interrelationships between the concentration and size of the largest high-density lipoprotein subfraction and apolipoprotein C-I in infants at birth and follow-up at 2-3 months of age and their parents.

  2013cites this paper
• Efficient systemic delivery of siRNA by using high-density lipoprotein-mimicking peptide lipid nanoparticles.

  2012cites this paper
• Enhancement of HDL Formation and Normalization of Intravascular HDL Remodeling

  2011cites this paper